or
forgot password
  • cancer clinical trials in hackensack, NJ

  • Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
    The Cancer Center Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Multiple Myeloma
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    John Theurer Cancer Center at Hackensack University MC
    Hackensack, New Jersey 07601
    Ovarian Cancer
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Northern New Jersey Cancer Associates
    Hackensack, New Jersey 07601
    Peripheral T-cell Lymphoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Leukemia
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Leukemia, Lymphoma
    A Study of Carfilzomib Maintenance Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
    John Theurer Cancer Center at Hackensack UMC
    Hackensack, New Jersey 07601
    Multiple Myeloma
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Hackensack University Medical CCOP
    Hackensack, New Jersey 07601
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Leukemia, Lymphoma
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Tissue From Young Patients With Cancer
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Cancer
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Lymphoma
    Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
    Hackensack University Medical Center DeptofHackensackUniv.MedCtr.
    Hackensack, New Jersey 07601
    Renal Cell Carcinoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Neuroblastoma
    Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
    John Theurer Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Glioblastoma Multiforme
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Brain and Central Nervous System Tumors
    Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Renal Cell Carcinoma, Graft-Versus-Host Disease, Engraftment Syndrome
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    Hackensack University Medical Center Dept.of HackensackUniv.MedCtr.
    Hackensack, New Jersey 07601
    Myelodysplastic Syndromes
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Hackensack University Medical CCOP
    Hackensack, New Jersey 07601
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    Stem Cell Related Donor Safety Study
    John Theurer Cancer Center - Hackensack University Medcial Center
    Hackensack, New Jersey 07601
    Related Hematopoietic Stem Cell Donors
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Hackensack University Medical Center

    Trial Locations
    Hackensack University Medical Center
    Hackensack University Medical CCOP
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Relapsed or Refractory Chronic Lymphocytic Leukemia
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    START Rollover Study
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Leukemia
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Lymphoma, Lymphoproliferative Disorder
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Multiple Myeloma
    A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Non Small Cell Lung Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
    John Theurer Cancer Center
    Hackensack, New Jersey 07601
    Prostate Cancer
    Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
    John Theurer Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Relapsed Multiple Myeloma
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Chronic GVHD
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Multiple Myeloma
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    John Theurer Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Peripheral T-cell Lymphoma
    Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia

    Hackensack, New Jersey 07601
    Relapsed Multiple Myeloma, Refractory Multiple Myeloma, Waldenstrom Macroglobulinemia
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Hackensack University Medical CCOP
    Hackensack, New Jersey 07601
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Leukemia
    A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Male or Female Patients With a Serious or Immediately Life-threatening, Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or, Monkeypox Viruses(s) Who Have a Life Expectancy of ≥ 2 Weeks and for, Whom no Comparable or Satisfactory Alternative Therapy is Available
    Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
    Northern New Jersey Cancer Associates
    Hackensack, New Jersey 07601
    Acute Myeloid Leukemia (AML)
    Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Childhood Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Bladder Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
    John Theurer Cancer Center at Hackensack University
    Hackensack, New Jersey 07601
    Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Neuroendocrine Tumors of Non-Pancreatic Origin, Hormone Receptor-Positive Breast Cancer
    Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia
    John Theurer Cancer Center
    Hackensack, New Jersey 07601
    Acute Myeloid Leukemia
    Natural History Study of SCID Disorders
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    SCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA Deficiency, XSCID
    Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
    For additional information regarding sites for this trial call (919) 465-4648
    Hackensack, New Jersey 07601
    Chronic Lymphocytic Leukemia (CLL)
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
    John Theurer Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Leukemia, Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia
    A Phase I Dose-Escalation and PK Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
    HUMC
    Hackensack, New Jersey 07601
    AML, ALL, Blast Crisis, MDS, Multiple Myeloma
    PONATINIB for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)
    Northern New Jersey Cancer Associates, Site #128
    Hackensack, New Jersey 07601
    Chronic Myeloid Leukemia (CML), Ph+ Acute Lymphoblastic Leukemia (ALL)